Urmi R. Bhatt

Statistics

Publications

Citations

107

H-Index

Active since

2010

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Urmi R. Bhatt is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in enzyme inhibition, drug discovery, and medicinal chemistry.

Publications per year

2010–2013

Publications

Design and Synthesis of Prolylcarboxypeptidase (PrCP) Inhibitors To Validate PrCP As A Potential Target for Obesity

Changyou Zhou, Margareta Garcia-Calvo, Shirly Pinto et al. · Journal of Medicinal Chemistry · 2010 · 51 citations · Full text

Life Sciences, Medicinal Chemistry, Pharmacology +12

Discovery of benzimidazole pyrrolidinyl amides as prolylcarboxypeptidase inhibitors

Hong C. Shen, Fa‐Xiang Ding, Changyou Zhou et al. · Bioorganic & Medicinal Chemistry Letters · 2011 · 19 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +10

The discovery of non-benzimidazole and brain-penetrant prolylcarboxypeptidase inhibitors

Thomas H. Graham, Hong C. Shen, Wensheng Liu et al. · Bioorganic & Medicinal Chemistry Letters · 2011 · 16 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +6

Discovery of a new class of potent prolylcarboxypeptidase inhibitors derived from alanine

Zhicai Wu, Cangming Yang, Yusheng Xiong et al. · Bioorganic & Medicinal Chemistry Letters · 2011 · 11 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +13

Discovery and optimization of orally active cyclohexane-based prolylcarboxypeptidase (PrCP) inhibitors

John S. Debenham, Thomas H. Graham, Andreas Verras et al. · Bioorganic & Medicinal Chemistry Letters · 2013 · 10 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +8

1–5 of 5